Table 3. Characteristics of patients with positive crossmatch.
| No. | Sex/Age | Blood type | Primary diagnosis | Days on waitlist | Preop ECMO | Distribution of XM | PRA, % | cPRA, % | DSA | Desensitization | PGD grade | Acute rejection | 1-yr mortality | Cause of death | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T lymphocytes | B lymphocytes | Class I (MFI) | Class II (MFI) | 48 hr | 72 hr | Dx | POD | Bx proven | AMR | Treatment | |||||||||||
| 1 | F/53 | A | CTD-ILD | 15 | Yes | CDC+/Flow− | CDC+/Flow− | 1 | - | - | DR8 (1,000) | No | 0 | 0 | No | - | Not done | No | - | Yes | Respiratory failure |
| 2 | F/62 | B | Eisenmenger syndrome | 26 | Yes | CDC+/Flow+ | CDC−/Flow+ | - | - | - | - | No | 0 | 0 | No | - | No | No | - | Yes | Liver disease |
| 3 | M/67 | B | IPF | 65 | No | CDC−/Flow+ | CDC−/Flow+ | 73 | - | - | DR12 (584) | Yes | 0 | 0 | Yes | 47 | Yes | No | Steroid pulse | No | - |
| DR13 (653) | |||||||||||||||||||||
| 4 | F/62 | A | CTD-ILD | 306 | No | CDC−/Flow− | CDC−/Flow+ | 17 | - | - | DQ7 (1,300) | Yes | 0 | 0 | Yes | 12 | Yes | No | Steroid pulse | No | - |
| 5 | F/52 | O | IPF | 670 | Yes | CDC+/Flow− | CDC+/Flow− | - | 98 | A11 (12,768) | DR1 (17,497) | No | 0 | 0 | No | - | Not done | No | - | Yes | Infection |
| B13 (10,172) | DR51 (17,460) | ||||||||||||||||||||
| DR9 (15,366) | |||||||||||||||||||||
| DR53 (13,446) | |||||||||||||||||||||
| 6 | F/44 | AB | CTD-ILD | 124 | No | CDC+/Flow− | CDC+/Flow− | 75 | - | B35 (11,037) | - | Yes | 0 | 0 | Yes | 1 | Not done | Yes | Steroid pulse | No | Retransplantation |
| B13 (8,306) | Plasmapheresis | ||||||||||||||||||||
| IVIG | |||||||||||||||||||||
| 7 | F/61 | A | CTD-ILD | 125 | No | CDC+/Flow+ | CDC−/Flow− | - | 67 | A11 (10,000) | - | Yes | 0 | 0 | No | - | Not done | No | - | Yes | Infection |
| B62 (10,000) | |||||||||||||||||||||
| 8 | F/68 | AB | CTD-ILD | 52 | No | CDC−/Flow− | CDC−/Flow+ | - | - | NA | NA | No | 0 | 0 | No | - | Not done | No | - | No | - |
| 9 | F/54 | AB | ARDS | 3 | No | CDC−/Flow+ | CDC−/Flow+ | - | - | B13 (3,080) | - | Yes | 3 | 2 | No | - | Not done | No | - | No | - |
| B48 (2,937) | |||||||||||||||||||||
XM = crossmatch, CTD-ILD = connective tissue-related interstitial lung disease, ECMO = extracorporeal membrane oxygenation, CDC = complement-dependent cytotoxicity, PRA = panel-reactive antibody, DSA = donor specific antibodies, PGD = primary graft dysfunction, MFI = mean fluorescence intensity, AMR = antibody-mediated rejection, ARDS = acute respiratory distress syndrome, IPF = idiopathic pulmonary fibrosis, IVIG = intravenous immunoglobulin.